{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-013638","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2026-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.902993+00:00","generated_at":"2026-05-15T02:41:25.311625+00:00","sec_items":[],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Filana Therapeutics board member Michael O'Donnell resigns effective at 2026 annual meeting","bullets":["Michael O'Donnell notified Filana's Board of his resignation on April 22, 2026.","Resignation is effective at the conclusion of the 2026 annual meeting of stockholders.","O'Donnell will continue to serve as a director until the effective date.","Resignation was not due to any disagreement with Company, management, or Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013638","json":"https://secwatch.observer/filing/0001437749-26-013638.json","markdown":"https://secwatch.observer/filing/0001437749-26-013638.md","text":"https://secwatch.observer/filing/0001437749-26-013638.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926013638/0001437749-26-013638-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926013638/sava20260427_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:41:25.311625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}